The injectable drug delivery method is an important tool used by
medical professionals to provide a drug dose to a patient directly
through his body, thereby reducing the threat of overdose, and
streamlining drug release. Such a system leverages a faster and
more controlled drug release into the bloodstream.
WILMINGTON, Del., July 15, 2024 /PRNewswire/ -- The projected size
of the global injectable drug delivery system market is likely to
reach USD 1.9 trillion by 2034. This
advancement of the industry is estimated to reach this value at
a promising CAGR of 9.8% through the forecasted
period, which lifted the valuation from the USD 689.5 billion mark, measured in 2023.
The spurring incidences of patients affected due to chronic
diseases are likely to affect the size of the competitive space.
With the rising prevalence of diseases, the demand for relevant
drugs, medicines, and medical assistance is expected to proliferate
in the forecast period.
The cases of patients infected due to several infectious
diseases like malaria and influenza are increasing. To cater to the
effective medication demand, medical professionals are investing
more in the development of appropriate drugs and suitable drug
delivery methods and systems.
Along with such infectious diseases, chronic illnesses like
cancer, cardiovascular diseases, pulmonary disorders, and many more
are expected to spread rapidly. This accelerated prevalence of
diseases is expected to drive the demand for the appropriate drug
delivery system. This demand is likely to drive the demand for the
competitive space.
The consumer inclination is observed to have risen toward
minimally invasive therapies and treatments. As a result, more
attention is being given to the rising necessity of a relevant
system, which elaborates the spurring demand for an injectable drug
delivery system.
Unlock Growth Potential in Your Industry - Get Your Sample
PDF Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1336
Medical professionals are keen on increasing the
user-friendliness of treatments to provide better comfort to
patients. As a result, the demand for injectable drug delivery
systems is expected to rise, creating several prospects for key
players in the competitive space.
The rising technological advancements are another driving force,
proliferating the progress of the ecosystem. Key players are
integrating cutting-edge tools, including AI, IoT, cloud computing,
and many more, which elevate the dosage, and timing of drug
delivery, and more.
Along with streamlining drug dosage, drug formulation can also
be augmented. This helps medical professionals provide personalized
treatments and therapies to patients, depending on the individual's
requirements. With the use of such systems, the precision of the
dosage provided increases. As a result, this factor drives the
global injectable drug delivery market size.
Key Findings from the Market Report
- The competitive landscape of the global injectable drug
delivery market is segmented into different categories based on key
parameters. Based on the product type, conventional injection
devices will gain more attention due to the growing number of
surgeries across the world.
- Based on therapeutic applications, the prevalence of chronic
diseases will drive the demand for cancer therapies. As a result,
the category is likely to gain more traction in the competitive
space.
- The usage pattern might vary, depending on an individual's
response to different diseases. As vaccination has increased
worldwide, the demand for immunization might also surge, driving
the category.
- Due to the better availability of medical assistance,
hospitals, and clinics are expected to gain more attention in the
competitive space.
Injectable Drug Delivery Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 689.5 Bn
|
Forecast (Value) in
2034
|
US$ 1.9 Trn
|
Growth Rate
(CAGR)
|
9.8 %
|
No. of
Pages
|
263
Pages
|
Segments
covered
|
By Product Type, By
Therapeutic Application, By Usage Pattern, By End-user, By
Region
|
Regional Profile
- Owing to the robustness of the healthcare infrastructure,
North America might lead the
global injectable drug delivery market.
- The growing demand for minimally invasive treatments in
Asia-Pacific might fuel the demand
for such treatments, creating prospects for key players in the
realm.
- Technological advancements might spur research and development
in Europe. This is a key
contributing factor to the development of the ecosystem.
Competitive Landscape
Owing to strategies like product innovation and differentiation,
key players are likely to expand in the industry.
- Becton, Dickinson, and Company is a key player that offers
products like PosiFlush pre-filled saline syringes, Power Midline
catheters, and many more.
- Pfizer, Inc. is another important marketer, offering ACCURETIC,
ADENOSINE, and AMINOCAPROIC ACID.
- Eli Lilly and Company offers diversified products, including
Dulaglutide, Insulin Lispro, and Insulin Glargine I.P solution for
injection.
Key Developments in the Injectable Drug Delivery
Market
- In September 2023, Pfizer, Inc.
introduced ABRYSVO for RSV, aiming to diversify its product
portfolio, which was recommended by CDC Advisory Committee.
- In June 2024, Becton, Dickinson,
and Company acquired Edwards Lifesciences' Critical Care Product
Group. The transaction cost about USD 4.2
billion.
Key Players
- Becton, Dickinson, and Company (BD)
- Pfizer, Inc.
- Eli Lilly and Company
- Baxter International, Inc.
- Terumo Corporation
- B. Braun Melsungen AG
- Ypsomed AG
- Gerresheimer AG
- SCHOTT Pharma
- Hi-Tech Syringes
Market Segmentation
Product Type
- Devices
- Conventional Injection Devices
- Self-injection Devices
- Others
Formulations
- Conventional Drug Delivery Formulations
- Novel Drug Delivery Formulations
- Long Lasting Injection Formulations
Therapeutic Application
- Autoimmune Disease
- Hormone Disease
- Orphan Disease
- Cancer
- Cardiovascular Disease
- Infectious Disease
- Others
Usage Pattern
- Curative Care
- Immunization
- Others
End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Drive Your Growth Strategy: Purchase the Report for Key
Insights!
https://www.transparencymarketresearch.com/checkout.php?rep_id=1336<ype=S
Have a Look at Related Reports of Healthcare Domain:
- Dialysis Equipment Market - The global dialysis
equipment industry was worth US$ 16.0
Billion in 2022. According to estimates, the industry will
expand at a CAGR of 5.5% from 2023 to 2031. The market is
estimated to reach over US$ 25.2
billion by 2031. Researchers are exploring new ways to
restore kidney function in regenerative medicine, removing the need
for dialysis in the long run.
- Contact Lens Market - The global contact lens
market was estimated to have acquired US$
7.9 billion in 2022. It is anticipated to register a 5.5%
CAGR from 2023 to 2031 and by 2031; the market is likely to
gain US$ 12.6 billion.
- Insulin-like Growth Factors Market – Market for
Insulin-like Growth Factors is expected to grow at a CAGR of 5.8%
from 2024 to 2034 and reach US$ 511.4
Mn by the end of 2034
- Fibromyalgia Treatment Market - Global Fibromyalgia
Treatment Market was valued at US$ 1.9
Bn in 2023, is expected to grow at a CAGR of 3.8% from 2024
to 2034 and reach US$ 2.9 Bn by the
end of 2034
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington,
Delaware, United States,
provides custom research and consulting services. Our exclusive
blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use
proprietary data sources and various tools & techniques to
gather and analyses information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER
DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/transparency-market-research-inc-forecasts-injectable-drug-delivery-market-to-reach-us-1-9-trillion-by-2034--fueled-by-growing-demand-for-generic-medicines-and-biosimilars-302196816.html